1. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  2. GEO-RA Group. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin. Rheumatol. 2017;36 (3):485-497. doi: 10.1007/s10067-016-3481-9. PubMed PMID:27995382 .
  3. Osiri, M, Wongpiyabovorn, J, Sattayasomboon, Y, Thammacharoenrach, N. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics. Clin. Rheumatol. 2016;35 (7):1673-81. doi: 10.1007/s10067-016-3306-x. PubMed PMID:27188857 .
  4. Akawatcharangura, P, Taechakraichana, N, Osiri, M. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand. Lupus. 2016;25 (4):436-44. doi: 10.1177/0961203315617539. PubMed PMID:26621134 .
  5. Osiri, M, Sattayasomboon, Y. Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis. Joint Bone Spine. 2013;80 (6):608-12. doi: 10.1016/j.jbspin.2013.01.013. PubMed PMID:23827409 .
  6. Osiri, M. Pharmacotherapy: Is there a place for leflunomide in the treatment of RA?. Nat Rev Rheumatol. 2010;6 (7):387-9. doi: 10.1038/nrrheum.2010.76. PubMed PMID:20596051 .
  7. Rubbert-Roth, A, Tak, PP, Zerbini, C, Tremblay, JL, Carreño, L, Armstrong, G et al.. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Rheumatology (Oxford). 2010;49 (9):1683-93. doi: 10.1093/rheumatology/keq116. PubMed PMID:20463186 PubMed Central PMC2919195.
  8. Rutjes, AW, Nüesch, E, Sterchi, R, Kalichman, L, Hendriks, E, Osiri, M et al.. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database Syst Rev. 2009; (4):CD002823. doi: 10.1002/14651858.CD002823.pub2. PubMed PMID:19821296 .
  9. Osiri, M, Wongchinsri, J, Ukritchon, S, Hanvivadhanakul, P, Kasitanon, N, Siripaitoon, B et al.. Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis. Arthritis Res. Ther. 2009;11 (4):R129. doi: 10.1186/ar2796. PubMed PMID:19709443 PubMed Central PMC2745813.
  10. Osiri, M, Tantawichien, T. Staphylococcus aureus thymic abscesses associated with anti-tumour necrosis factor therapy. Scand. J. Rheumatol. ;36 (4):320-1. doi: 10.1080/03009740601154392. PubMed PMID:17763211 .
  11. Osiri, M, Kamolratanakul, P, Maetzel, A, Tugwell, P. Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis. Rheumatol. Int. 2007;27 (11):1063-9. doi: 10.1007/s00296-007-0342-5. PubMed PMID:17440729 .
  12. Osiri, M, Maetzel, A, Tugwell, P. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand. J. Rheumatol. 2007;34 (1):57-63. . PubMed PMID:17183621 .
  13. Osiri, M, Deesomchok, U, Tugwell, P. Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice. Clin. Rheumatol. 2006;25 (5):721-7. doi: 10.1007/s10067-005-0155-4. PubMed PMID:16365685 .
  14. Siripaitoon, B, Osiri, M, Vongthavaravat, V, Akkasilpa, S, Deesomchok, U. The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus. Lupus. 2004;13 (12):961-8. doi: 10.1191/0961203304lu1084xx. PubMed PMID:15645754 .
  15. Akkasilpa, S, Osiri, M, Deesomchok, U, Avihingsanon, Y. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia. J Med Assoc Thai. 2004;87 (9):1087-91. . PubMed PMID:15516011 .
  16. Osiri, M, Shea, B, Robinson, V, Suarez-Almazor, M, Strand, V, Tugwell, P et al.. Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J. Rheumatol. 2003;30 (6):1182-90. . PubMed PMID:12784387 .
  17. Osiri, M, Suarez-Almazor, ME, Wells, GA, Robinson, V, Tugwell, P. Number needed to treat (NNT): implication in rheumatology clinical practice. Ann. Rheum. Dis. 2003;62 (4):316-21. doi: 10.1136/ard.62.4.316. PubMed PMID:12634229 PubMed Central PMC1754501.
  18. Osiri, M, Shea, B, Robinson, V, Suarez-Almazor, M, Strand, V, Tugwell, P et al.. Leflunomide for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2003; (1):CD002047. doi: 10.1002/14651858.CD002047. PubMed PMID:12535423 .
  19. Wongchinsri, J, Tantawichien, T, Osiri, M, Akkasilpa, S, Deesomchok, U. Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients. J Med Assoc Thai. 2002;85 Suppl 1 :S34-9. . PubMed PMID:12188433 .
  20. Osiri, M, Deesomchok, U, Tugwell, P. Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology (Oxford). 2001;40 (5):555-8. doi: 10.1093/rheumatology/40.5.555. PubMed PMID:11371665 .
  21. Akkasilpa, S, Osiri, M, Ukritchon, S, Junsirimongkol, B, Deesomchok, U. Clinical features of septic arthritis of sternoclavicular joint. J Med Assoc Thai. 2001;84 (1):63-8. . PubMed PMID:11281502 .
  22. Osiri, M, McNicholl, J, Moreland, LW, Bridges, SL Jr. A novel single nucleotide polymorphism and five probable haplotypes in the 5' flanking region of the IL-6 gene in African-Americans. Genes Immun. 1999;1 (2):166-7. doi: 10.1038/sj.gene.6363652. PubMed PMID:11196667 .
  23. Osiri, M, Moreland, LW. Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy. Arthritis Care Res. 1999;12 (5):351-62. . PubMed PMID:11081005 .
  24. Osiri, M, Welch, V, Brosseau, L, Shea, B, McGowan, J, Tugwell, P et al.. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database Syst Rev. 2000; (4):CD002823. doi: 10.1002/14651858.CD002823. PubMed PMID:11034768 .
  25. Osiri, M, Saag, KG, Ford, AM, Moreland, LW. Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis. J Clin Rheumatol. 2000;6 (3):117-22. . PubMed PMID:19078458 .
  26. Osiri, M, Akkasilpa, S, Deesomchok, U. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study. J Med Assoc Thai. 2000;83 (3):217-24. . PubMed PMID:10808674 .
  27. Osiri, M, Ruxrungtham, K, Nookhai, S, Ohmoto, Y, Deesomchok, U. IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis. Asian Pac. J. Allergy Immunol. 1998;16 (4):155-60. . PubMed PMID:10219896 .
  28. Osiri, M, Tantawichien, T, Deesomchock, U. Edwardsiella tarda bacteremia and septic arthritis in a patient with diabetes mellitus. Southeast Asian J. Trop. Med. Public Health. 1997;28 (3):669-72. . PubMed PMID:9561628 .
  29. Osiri, M, Akkasilpa, S, Reinprayoon, S, Deesomchok, U. Streptococcal arthritis in Thai adults: case series and review. J Med Assoc Thai. 1996;79 (12):755-61. . PubMed PMID:9071078 .
Search PubMed